Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04228367 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

JuggerStitch Post Market Clinical Follow-up Study

StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Results posted: Sep 24, 2026 Trial completed · Primary completion date changed from estimate of Mar 31, 2026 to Apr 30, 2026 · Eligibility criteria expanded, about 12 words · 1 more Show 4 more changesShow less
    • Trial completed
    • Primary completion date changed from estimate of Mar 31, 2026 to Apr 30, 2026
    • Eligibility criteria expanded, about 12 words
    • Secondary endpoints: details revised at 6 of 6 entries
  2. Secondary endpoints revised (6)v17 See this version in full on ClinicalTrials.gov ↗
  3. Trial status: Recruiting to Completed Enrollment target: estimated 104 to confirmed 103 · Primary completion date changed from estimate of Mar 31, 2026 to Apr 30, 2026 · Study completion date changed from estimate of Apr 30, 2026 to May 31, 2026 · 2 morev16 Show 5 more changesShow less
    • Enrollment target: estimated 104 to confirmed 103
    • Primary completion date changed from estimate of Mar 31, 2026 to Apr 30, 2026
    • Study completion date changed from estimate of Apr 30, 2026 to May 31, 2026
    • Secondary endpoints: 1 to 6
    • Site details revised at 6 of 6 sites

    See this version in full on ClinicalTrials.gov ↗

  4. Site details revised at 1 of 6 sitesv15
  5. Primary completion date: Aug 31, 2025 to Mar 31, 2026 Completion date: Aug 31, 2026 to Apr 30, 2026v14 Show 1 more changeShow less
    • Completion date: Aug 31, 2026 to Apr 30, 2026
Show 12 earlier versionsHide 12 earlier versions
  1. Enrollment target: 130 to 104v13
  2. Primary completion date: Apr 1, 2025 to Aug 31, 2025 Completion date: Nov 30, 2025 to Aug 31, 2026v12 Show 1 more changeShow less
    • Completion date: Nov 30, 2025 to Aug 31, 2026
  3. Site details revised at 1 of 6 sitesv11
  4. 2 versions Re-verified since Sep 4, 2023, no change to tracked fieldsv9-v10
  5. Primary completion date: Apr 1, 2023 to Apr 1, 2025 Study sites: 5 to 6 · Completion date: Nov 30, 2023 to Nov 30, 2025v8 Show 2 more changesShow less
    • Study sites: 5 to 6
    • Completion date: Nov 30, 2023 to Nov 30, 2025
  6. Study sites: 4 to 5 Primary completion date: Nov 1, 2022 to Apr 1, 2023 · Completion date: Mar 31, 2023 to Nov 30, 2023v7 Show 2 more changesShow less
    • Primary completion date: Nov 1, 2022 to Apr 1, 2023
    • Completion date: Mar 31, 2023 to Nov 30, 2023
  7. Primary completion date: Nov 1, 2021 to Nov 1, 2022 Study sites: 1 to 4 · Completion date: Mar 31, 2022 to Mar 31, 2023v6 Show 2 more changesShow less
    • Study sites: 1 to 4
    • Completion date: Mar 31, 2022 to Mar 31, 2023
  8. Re-verified, no change to tracked fieldsv5
  9. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 1 · Start date changed from estimate of Aug 1, 2020 to Sep 25, 2020v4 Show 2 more changesShow less
    • Study sites: 0 to 1
    • Start date changed from estimate of Aug 1, 2020 to Sep 25, 2020
  10. Start date: Mar 1, 2020 to Aug 1, 2020v3
  11. Primary endpoint revised Secondary endpoint revised · Eligibility criteria expanded, about 3 wordsv2 Show 2 more changesShow less
    • Secondary endpoint revised
    • Eligibility criteria expanded, about 3 words

    See this version in full on ClinicalTrials.gov ↗

  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Zimmer Biomet
83 trials monitored
See 1 trial at risk
This study is a post-market follow-up study. The data collected from this study will serve the purpose of confirming the safety and performance of the JuggerStitch Device used for meniscal repair according to the product labelling (Instruction For Use).
Trial Details
NCT Number NCT04228367
Lead Sponsor Zimmer Biomet
Conditions Meniscus Tear, Tibial, Meniscus Lesion
Enrollment 103 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov